NeuroSense Therapeutics L... (NRSN)
1.01
0.02 (2.34%)
At close: Apr 24, 2025, 12:17 PM
13F Institute Ownership
Total Institutes of 13 in NeuroSense Therapeutics expanded their positions with an increase of 6 investors compared to the previous quarter. An additional 421.16K shares, as total invested capital grew by $489.95K with ownership percentage increasing from 1.25% to 3.58%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 1.41% | 254K | +640.95% | 304.8K | < 0.01% |
| Morgan Stanley | 0.57% | 102.58K | +100.00% | 123.1K | < 0.01% |
| Jane Street Group, LLC | 0.36% | 64.64K | +100.00% | 77.56K | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.